Sort
39,280 grants matching “leukemia”
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
$610,603Brad Kahl · University Of Wisconsin-Madison · U10 · FY2008 · CA
Administrative and Informatics
$610,335Thomas J. Kipps · University Of California, San Diego · P01 · FY2015 · CA
Apolipoprotein M: a novel regulator of myocardial Autophagy
$610,273Ali Javaheri · Washington University · R01 · FY2023 · HL
An Integrative Approach to Evaluate Neurocognitive Disparities in Latinos Undergoing Treatment for Childhood Leukemia.
$610,229Kimberly Pauline Raghubar · Baylor College Of Medicine · R01 · FY2024 · CA
Therapeutic implication of CD38 in CLL
$610,215Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2021 · CA
Therapeutic implication of CD38 in CLL
$610,215Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2020 · CA
Therapeutic implication of CD38 in CLL
$610,213Asher A Chanan-Khan · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
$610,105Jin Wang · Baylor College Of Medicine · R01 · FY2024 · CA
Targeting GSK3B in refractory B-cell malignancies
$610,056Markus Mãschen · Yale University · R01 · FY2023 · CA
Brain Tumors - Immunological and Biological Studies
$609,977Duke University · R37 · FY2003 · CA
Project 1: Role of emergency myelopoiesis as a driver of clonal evolution in AML
$609,976Emmanuelle Passegue · Columbia University Health Sciences · P01 · FY2025 · CA
Project 1: Role of emergency myelopoiesis as a driver of clonal evolution in AML
$609,976Emmanuelle Passegue · Columbia University Health Sciences · P01 · FY2024 · CA
Biochemistry of Leukemia Virus Core-Binding Factor
$609,952Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2022 · HL
Biochemistry of Leukemia Virus Core-Binding Factor
$609,952Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2023 · HL
Multiplex Detection of Mutations in Leukemia Patients
$609,861Emmanuel Labourier · Ambion Diagnostics, Inc. · R44 · FY2009 · CA
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
$609,576Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Genomic Architecture of LGL Leukemia
$609,457Thomas P Loughran · University Of Virginia · R01 · FY2017 · CA
Core B
$609,379David F Claxton · University Of Virginia · P01 · FY2025 · CA
FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS
$609,318Beerelli Seshi · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R33 · FY2006 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2025 · CA
Trispecific CAR-T cells targeting CD19, CD20 and CD22 to treat B-cell malignancies
$609,273Sumithira Vasu · Ohio State University · R01 · FY2023 · CA
Lnk Regulatory Functions in Hematopoietic Stem Cells
$609,184Wei Tong · Children'S Hosp Of Philadelphia · R01 · FY2020 · HL
Instructive role of MLL fusion proteins in lineage determination and leukemogenesis
$609,178Michael J Thirman · University Of Chicago · R01 · FY2017 · CA
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
$609,103Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Genomic Architecture of LGL Leukemia
$609,097Thomas P Loughran · University Of Virginia · R01 · FY2018 · CA